| Primary information |
|---|
| sequence ID | Seq_3284 |
| Peptide sequence | GTYVSSVPR |
| CancerPDF_ID | CancerPDF_ID11533, CancerPDF_ID13070, |
| PMID | 26992070,20974924 |
| Protein Name | "HLA class II histocompatibility antigen, DO alpha chain","HLA class II histocompatibility antigen, DO alpha chain" |
| UniprotKB Entry Name | DOA_HUMAN,DOA_HUMAN |
| Fluid | Serum,Plasma |
| M/Z | 964.49779,965.506 |
| Charge | NA,2 |
| Mass (in Da) | 965.5043811,NA |
| fdr | NA,NA |
| Profiling Technique | LC-MS,LC-MS |
| Peptide Identification technique | LC-MS/MS,LC-MS/MS |
| Quantification Technique | NA,NA |
| Labelled/Label Free | Label Free,Label Free |
| FDR | FDR 1 %,NA |
| CancerPDF_ID | CancerPDF_ID11533, CancerPDF_ID13070, |
| p-Value | NA,NA |
| Software | SEQUEST and Maxquant,MASCOT and SEQUEST |
| Length | 9,NA |
| Cancer Type | Melanoma,"Multiple myeloma patients, Acute myeloid leukemia" |
| Database | SwissProt Database,Uniprot database |
| Modification | NA,NA |
| Number of Patients | 8 cancer samples and 4 healthy samples,NA |
| Regulation | "Present in 3 cancer samples out of 8 cancer samples. ,Present in 2 healthy samples out of 4 healthy samples.",NA |
| Validation | na,NA |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | NA |
| IEDB | 162402
|